Lutein for Cognitive Function

Verdict: Preliminary, inconsistent evidence for cognition

Lutein (almost always combined with zeaxanthin) shows only weak, preliminary signals for cognition in older adults: a few small trials report gains in narrow domains, but the pooled meta-analysis found no significant overall effect, so it is not an established cognitive aid.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade reflects small, inconsistent human data. Four short-to-medium-term RCTs (n approximately 44 to 90) reported domain-specific gains: complex attention and cognitive flexibility (PMID 28824416), buffered verbal-learning decline with increased prefrontal activation on fMRI (PMID 28695791, Cohen's d 0.84), and improved visual episodic memory and visual learning (PMID 35252311). However, a 2021 meta-analysis of RCTs (PMID 34641336) found no statistically significant overall cognitive effect, and a 52-week brain-morphology trial (PMID 31871787) showed negligible between-group differences.

Several caveats prevent a higher grade. The trials are small and short, lutein was co-administered with zeaxanthin so its effect cannot be isolated, and two studies (PMID 35252311, PMID 31871787) carry industry conflicts of interest, raising the risk of optimistic reporting.

Regulators and clinicians do not endorse this use. The US FDA accepts lutein only as a safe food ingredient (GRAS) and previously rejected eye-health claims; the UK NHS advises prescribers not to initiate lutein-and-antioxidant products; WHO addresses only additive safety (ADI 'not specified'); and clinical bodies (Cleveland Clinic, plus the Alzheimer's Association and American Academy of Neurology) remain cautious, holding that no supplement is proven to benefit cognition.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.59
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
81%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L3 MechanismPlausibility
0.65
L2 PubMedPrimary literature
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.588
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial
PMID: 28824416 2017 隨機對照試驗 n = 51
Finding: 補充組在複雜注意力(p < 0.02)與認知彈性(p < 0.04)有統計顯著改善,執行功能呈趨勢;男性受試者綜合記憶亦改善(p = 0.04)
🟠 Limited quality Effect size: 未報告標準化效果量,僅提供 p 值
View on PubMed
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
PMID: 28695791 2018 隨機對照試驗 n = 44
Finding: 補充組緩衝了語文學習任務的認知衰退,並在左側背外側前額葉與前扣帶皮質出現較高活化,提示腦部灌流增強
🟠 Limited quality Effect size: Cohen's d = 0.84(認知衰退緩衝)
View on PubMed
The Effects of Lutein and Zeaxanthin Supplementation on Cognitive Function in Adults With Self-Reported Mild Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Study
PMID: 35252311 2022 隨機對照試驗 n = 90
Finding: 補充組在視覺情節記憶(p = 0.005)與視覺學習(p = 0.001)改善幅度較大,但其他認知測驗與自評問卷皆無顯著差異;耐受性良好無顯著不良反應
Effect size: 未提供數值效果量,僅報告統計顯著性
View on PubMed
The Effects of Lutein and Zeaxanthin Supplementation on Brain Morphology in Older Adults: A Randomized, Controlled Trial
PMID: 31871787 2019 隨機對照試驗 n = 47
Finding: 兩組皆出現年齡相關的額顳葉灰白質下降,整體組間差異極小;惟 MPOD 增幅較大者全腦與前額葉灰質下降較少
🟠 Limited quality Effect size: 摘要未明列標準化效果量
View on PubMed
Dietary Lutein and Cognitive Function in Adults: A Meta-Analysis of Randomized Controlled Trials
PMID: 34641336 2021 統合分析
Finding: 彙整結果顯示膳食葉黃素未能在複雜注意力、執行功能與記憶領域一致改善認知功能,整體結果統計上不顯著;但葉黃素攝取對學習時的腦部活動、靜息連結與灰質體積可能有正向影響
Effect size: 整體領域效果量未達統計顯著
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
FDA has no questions; some uses may require a color additive listing source↗
L4b EU EFSA
Against
L4c UK NHS
Against
Prescribers should not initiate lutein and antioxidants for any new patient, and patients currently being prescribed these products should be reviewed and treatment stopped. source↗
L4d TW TFDA / 衛福部
Neutral
膠囊錠狀食品中每日食用量標示者,每人每日葉黃素食用量不得超過30毫克;未標示每日食用量者,每300公克中葉黃素含量不得超過9毫克。 source↗
L4e WHO
Not addressed
Based on the absence of toxicity in a wide range of studies, the Committee at its 86th meeting established a group ADI 'not specified' for lutein from Tagetes erecta, lutein esters from Tagetes erecta and zeaxanthin (synthetic). The decision was based on the absence of any observed toxicity of lutein or lutein esters in toxicological studies in animals, the absence of any adverse effects in hum… source↗
L5a NIH Office of Dietary Supplements
Supportive
L5c Cleveland Clinic
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-lutein-001 繁體中文版 →